GLI1 and neoplasm: An immunohistochemical analysis demonstrated the expression of Patched1, Gli1, and Gli2 in 70%, 70%, and 65% of human ONB cases, respectively, with Patched1 levels inversely and Gli1 levels positively correlating with the tumor severity based on Kadish staging and Hyams grading.